80 related articles for article (PubMed ID: 26866929)
1. A relaxometric method for the assessment of intestinal permeability based on the oral administration of gadolinium-based MRI contrast agents.
Gianolio E; Boffa C; Orecchia V; Bardini P; Catanzaro V; Poli V; Aime S
NMR Biomed; 2016 Apr; 29(4):475-82. PubMed ID: 26866929
[TBL] [Abstract][Full Text] [Related]
2. Determination of gadolinium-based magnetic resonance imaging contrast agents by micellar electrokinetic capillary chromatography.
Andrási M; Gáspár A; Kovács O; Baranyai Z; Klekner A; Brücher E
Electrophoresis; 2011 Aug; 32(16):2223-8. PubMed ID: 21792999
[TBL] [Abstract][Full Text] [Related]
3. A liposomal Gd contrast agent does not cross the mouse placental barrier.
Shetty AN; Pautler R; Ghaghada K; Rendon D; Gao H; Starosolski Z; Bhavane R; Patel C; Annapragada A; Yallampalli C; Lee W
Sci Rep; 2016 Jun; 6():27863. PubMed ID: 27298076
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent.
Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K
Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637
[TBL] [Abstract][Full Text] [Related]
5. Speciation analysis of gadolinium-based MRI contrast agents in blood plasma by hydrophilic interaction chromatography/electrospray mass spectrometry.
Künnemeyer J; Terborg L; Nowak S; Scheffer A; Telgmann L; Tokmak F; Günsel A; Wiesmüller G; Reichelt S; Karst U
Anal Chem; 2008 Nov; 80(21):8163-70. PubMed ID: 18821778
[TBL] [Abstract][Full Text] [Related]
6. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
7. Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry.
Künnemeyer J; Terborg L; Nowak S; Brauckmann C; Telgmann L; Albert A; Tokmak F; Krämer BK; Günsel A; Wiesmüller GA; Karst U
Electrophoresis; 2009 May; 30(10):1766-73. PubMed ID: 19441033
[TBL] [Abstract][Full Text] [Related]
8. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
9. Intestinal permeability and contractility in murine colitis.
van Meeteren ME; van Bergeijk JD; van Dijk AP; Tak CJ; Meijssen MA; Zijlstra FJ
Mediators Inflamm; 1998; 7(3):163-8. PubMed ID: 9705603
[TBL] [Abstract][Full Text] [Related]
10. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.
Frenzel T; Lengsfeld P; Schirmer H; Hütter J; Weinmann HJ
Invest Radiol; 2008 Dec; 43(12):817-28. PubMed ID: 19002053
[TBL] [Abstract][Full Text] [Related]
11. Exploring the tumour extracellular matrix by in vivo Fast Field Cycling relaxometry after the administration of a Gadolinium-based MRI contrast agent.
Baroni S; Ruggiero MR; Aime S; Geninatti Crich S
Magn Reson Chem; 2019 Aug; 57(10):845-851. PubMed ID: 30675933
[No Abstract] [Full Text] [Related]
12. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.
White GW; Gibby WA; Tweedle MF
Invest Radiol; 2006 Mar; 41(3):272-8. PubMed ID: 16481910
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of Lactobacillus paracasei alleviates clinical symptoms of colitis induced by dextran sulphate sodium salt in BALB/c mice.
Pan T; Guo HY; Zhang H; Liu AP; Wang XX; Ren FZ
Benef Microbes; 2014 Sep; 5(3):315-22. PubMed ID: 24889889
[TBL] [Abstract][Full Text] [Related]
14. [Effect of balsalazide on intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice].
Liu XC; Mei Q; Xu JM; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):193-6. PubMed ID: 19296261
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.
Taupitz M; Stolzenburg N; Ebert M; Schnorr J; Hauptmann R; Kratz H; Hamm B; Wagner S
Contrast Media Mol Imaging; 2013; 8(2):108-16. PubMed ID: 23281283
[TBL] [Abstract][Full Text] [Related]
17. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
20. Contrast-Enhanced µCT for Visualizing and Evaluating Murine Intestinal Inflammation.
Jung D; Heiss R; Kramer V; Thoma OM; Regensburger AP; Rascher W; Uder M; Neurath MF; Knieling F; Waldner MJ
Theranostics; 2018; 8(22):6357-6366. PubMed ID: 30613304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
